BAT plays A role in HFD induced changes of metabolic syndrome in a lipodystrophy mice model

来源 :世界中医药学会联合会中药药理专业委员会第七届学术会议、全国中药药理联合会第二届学术年会暨第20届中日健康学术研讨会 | 被引量 : 0次 | 上传用户:tai_2036580
下载到本地 , 更方便阅读
声明 : 本文档内容版权归属内容提供方 , 如果您对本文有版权争议 , 可与客服联系进行内容授权或下架
论文部分内容阅读
  Aim of study:Molecular mechanisms underlying the lipodystrophy associated metabolic syndrome remain unknown.Ap2-SREBP-1C transgenic mice overexpressing Nsrebp-1 c in adipose tissue under the control of the adipocyte-specific ap2 enhancer feature distinct adipose tissue disorders:barely existing WAT and compensatory hyperplasia of BAT,which contributes to dysfunction.As a result. ap2-SREBP-IC transgenic mice are characterized as models of type2 diabetes,hypercholesteremia and fatty liver.However,the relationship between imparing adipose function and insulin resistance needs to be further clarification.In this study,we aim to investigate the high food diet(HFD)effect on ap2-SREBP-IC mice.We want to observe whether BAT play a crucial role in IR.Material and methods:1 year old ap2-SREBP-lC transgenic mice and their littermates were randomly divided int0 4 groups:2 regular diet group(WT+RD group and TG+RD group) and 2 high fat diet group(WT+HFD group and TG+HFD group) lasting 6 months.The high fat diet consisted of 24% protein,41.0% carbohydrate,24.0% fat.During the experimental session,bodyweight gain,food-intake and water-intake were assayed every Thursday and Sunday.Tissue weigh of BAT.WAT.liver.muscle were calculated after dissection.Genes ACC.FAS in liver were determined by RT-PCR.Plasm levels of glucose,triglyceride,total cholesterol,free fatty acid,HDL-C,LDL-C,insulin,were determined using enzyme-linked immunosorbent assay.Levels of triglyceride,total cholesterol in liver and muscle were calculated by immunosorbent assay after homogenate.UCP-1 was detected by immunohistochemistry.Results:Our results indicated that compared to wildtype mice intaking HFD,BAT in ap2-SREBP-lc mice intaking HFD degenerated dramatically after 6 months HFD intake.BAT markers UCP-1 which is determined by immunohistochemistry expressed stronger.Weigh of WAT varies,weigh of liver in TG+HFD gains more than that in WT+HFD.Daily food intake.water intake and body weigh gain show no differences between each paired group.Levels of total cholesterol increased dramatically in TG+HFD group comparing to TG group,while TC show no differences between WT groups.Triglyceride increased after HFD inake in both WT and TG groups.There arent any accumulation of triglyceride and total cholesterol in muscle.Fasting plasma TC and HDL-C increased in TG+HFD.We also found increased level of CPTI/a in WT+HFD group,but reduced level in TG+HFD group,while compared to their control groups.ACC increased dramatically in TG+HFD group while only a litter in WT+HFD.Conclusions:Lipodystrohy related insulin resistance is closely related to BAT function.HFD intake can affect metabolic syndrome to some extent,whichBAT may play a crucial role.
其他文献
本文针对消毒供应中心回收医疗器械初消处理不合格、清洗剂使用不当、清洗不彻底等问题,提出开展业务学习与加强技术培训,定期开展新技术新知识的学习,对重复使用的医疗器械,按污染程度或器械结构形状进行规范的消毒和清洗处理,可以达到消毒和清洗质量要求,再辅助人工刷洗,可以确保洗涤质量,全面提升医用物品清洁灭菌工作的质量水平。
会议
会议
会议
会议
本文介绍了消毒供应中心采用集中管理模式,对所有需要消毒或灭菌后重复使用的诊疗器械,器具和物品由消毒供应中心回收,集中清洗,消毒,灭菌和供应。叙述了消毒供应中心去污区、检查包装区、无菌物品存放区作业流程的管理,提高了消毒供应中心的整体素质,节省了人力、物力,使物品的消毒、灭菌效果得到了保证,显著地降低了医院获得性感染的几率。
目的:研究三种不同浸泡溶液情况下手工清洗对气管内套管清洗效果的观察。方法:2009年1月-2009年4月,从全院收回的全部污染气管套管使用1%的过氧化氢浸泡30分钟后手工清洗,此为A组;2009年5月-2009年8月,从全院收回的全部污染气管内套管使用温度保持在30-40℃、浓度为1:200多酶清洗剂浸泡20分钟后手工清洗,此为B组;2009年9月-2009年12月,从全院收回的全部污染气管内套管
Objective:To study on the compatibility rule of tianhunag tablets based on metabonomics.Method:To take 40 SD male rats and feed them under SPF level environment.Then they were randomly divided into co
会议
Aim of study:Insulin resistance is the "common soil" of diabetes and cardiovascular disease.With significant morbidity,its targeted therapy method is still absent at present.Our Previous study shows t
Aim of study:Fu Fang Zhen Zhu Tiao Zhi formula (FTZ),for which a patent has been issued,is composed of eight medical herbs and has been proven clinically effective for the treatment of dyslipidemia. T